Haruko Yamamoto Selected Research

Nicardipine (Dagan)

10/2022	Early Hyperchloremia is Independently Associated with Death or Disability in Patients with Intracerebral Hemorrhage.
1/2022	Temporal Trajectory of Systolic Blood Pressure and Outcomes in Acute Intracerebral Hemorrhage: ATACH-2 Trial Cohort.
1/2022	Intensive blood pressure lowering with nicardipine and outcomes after intracerebral hemorrhage: An individual participant data systematic review.
10/2020	Systolic Blood Pressure Reduction and Acute Kidney Injury in Intracerebral Hemorrhage.
1/2016	Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Haruko Yamamoto Research Topics

Disease

17	Stroke (Strokes) 10/2022 - 01/2008
14	Cerebral Hemorrhage 10/2022 - 01/2012
10	Ischemic Stroke 03/2022 - 01/2008
5	Heart Failure 01/2022 - 04/2015
3	Hematoma 10/2022 - 01/2021
3	Thrombocytopenia (Thrombopenia) 08/2011 - 01/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2018
2	Lung Neoplasms (Lung Cancer) 12/2019 - 01/2017
2	Neoplasms (Cancer) 12/2019 - 01/2017
2	Tachycardia (Tachyarrhythmias) 01/2019 - 08/2017
1	Hemorrhage 10/2022
1	Hyperglycemia 04/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Congenital Heart Defects (Congenital Heart Defect) 01/2021
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021
1	Tissue Adhesions 10/2020
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2020
1	Respiratory Insufficiency (Respiratory Failure) 01/2020
1	Myocarditis (Carditis) 01/2020
1	Neoplasm Metastasis (Metastasis) 12/2019
1	Intracranial Aneurysm (Cerebral Aneurysm) 01/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018
1	Atherosclerosis 01/2018
1	Chronic Renal Insufficiency 01/2018
1	Cardiogenic Shock 01/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Albuminuria 01/2018
1	Premature Birth (Birth, Premature) 08/2017
1	Fetal Death 08/2017
1	Hydrops Fetalis (Fetal Edema) 08/2017
1	Central Nervous System Diseases (CNS Diseases) 08/2017
1	Cardiac Arrhythmias (Arrythmia) 08/2017
1	Cognitive Dysfunction 11/2016
1	Dementia (Dementias) 11/2016
1	Neurocognitive Disorders (Clerambault Syndrome) 11/2016
1	Death (Near-Death Experience) 04/2015
1	Heart Diseases (Heart Disease) 04/2015
1	Body Weight (Weight, Body) 12/2014
1	Pre-Eclampsia (Preeclampsia) 05/2014
1	Hemolysis 05/2014
1	HELLP Syndrome 05/2014
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2013
1	Hypertension (High Blood Pressure) 01/2012
1	Ischemia 02/2011
1	Infections 11/2010

Drug/Important Bio-Agent (IBA)

9	Antihypertensive Agents (Antihypertensives)IBA 10/2022 - 01/2012
8	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2022 - 01/2013
5	Nicardipine (Dagan)FDA LinkGeneric 10/2022 - 01/2016
3	Heparin (Liquaemin)FDA LinkGeneric 08/2011 - 01/2008
2	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 01/2018
2	Cytochrome P-450 CYP2C19IBA 03/2022 - 01/2019
2	CreatinineIBA 01/2022 - 10/2020
2	Eplerenone (Inspra)FDA LinkGeneric 01/2022 - 04/2015
1	Tenecteplase FDA Link 03/2022
1	AnticoagulantsIBA 02/2022
1	Mineralocorticoid Receptor AntagonistsIBA 01/2022
1	AdrenomedullinIBA 06/2021
1	Peptides (Polypeptides)IBA 06/2021
1	Warfarin (Coumadin)FDA LinkGeneric 01/2021
1	BAX602IBA 10/2020
1	landiololIBA 12/2019
1	Flecainide (Tambocor)FDA LinkGeneric 01/2019
1	Clopidogrel (Plavix)FDA Link 01/2019
1	Digoxin (Digitek)FDA LinkGeneric 01/2019
1	Sotalol (Sotalol Hydrochloride)FDA LinkGeneric 01/2019
1	Eicosapentaenoic AcidIBA 01/2018
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2018
1	Docosahexaenoic AcidsIBA 01/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	SodiumIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	dapagliflozinIBA 01/2018
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2018
1	Atrial Natriuretic Factor (ANF)IBA 01/2017
1	Cilostazol (Pletal)FDA LinkGeneric 11/2016
1	Amyloid (Amyloid Fibrils)IBA 11/2016
1	Phosphodiesterase InhibitorsIBA 11/2016
1	Pharmaceutical PreparationsIBA 11/2016
1	AldosteroneIBA 04/2015
1	EnzymesIBA 05/2014
1	Retinaldehyde (Retinal)IBA 02/2011
1	Complementary DNA (cDNA)IBA 11/2010

Therapy/Procedure

10	Therapeutics 01/2021 - 01/2008
3	Heart-Assist Devices 10/2020 - 01/2018
2	Perioperative Period 12/2019 - 01/2017
1	Thrombectomy 03/2022
1	Off-Label Use 01/2021
1	Extracorporeal Membrane Oxygenation 01/2020
1	Stents 01/2019
1	Endovascular Procedures 01/2019
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018
1	Cesarean Section (Caesarean Section) 08/2017
1	Aftercare (After-Treatment) 01/2013